Trial intelligence / Profile preview

Pharmacological Treatment of Narcotic Neonatal Withdrawal

NCT02810782Phase 3Completed

Sponsor
University of Zurich
Start
Jun 2001
Primary completion
Dec 2007
Modality
Allosteric Modulators
01

Overview

A Phase 3 trial of phenobarbital in neonatal abstinence syndrome (NAS), sponsored by University of Zurich. Started Jun 2001; status: completed.

02

Drugs

phenobarbital
03

Conditions

neonatal abstinence syndrome (NAS)

Beyond the preview

Go deeper on NCT02810782.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02810782.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call